Text size
related tags

Israeli pharmaceutical company Kamada raised $51.6 million in its initial public offering on Nasdaq last Friday, offering 5.6 million shares at $9.25 per share. That was16.6% below its Thursday closing price on the Tel Aviv Stock Exchange.